Delivery Order SPE2DE24D0013-SPE2D626F124A

Cepheid Inc. was awarded a delivery order valued at $2,944 by the Defense Logistics Agency Medical Supply Chain on November 12, 2025, with an ultimate completion date of November 19, 2025. This firm fixed-price delivery order, designated XPRSTREPA-10, carries no set-aside designation and is to be performed at Cepheid's headquarters location in Sunnyvale, California. The Defense Logistics Agency Medical Supply Chain, a defense-oriented federal entity responsible for managing medical supply procurement for the Department of Defense, has issued this delivery order to Cepheid as part of the company's established role as a primary federal supplier of molecular diagnostic solutions.

This delivery order represents a continuation of Cepheid's extensive federal contracting relationship, particularly with the Department of Defense and Veterans Affairs medical systems. Cepheid specializes in advanced molecular diagnostic systems and reagents, with core competencies in rapid molecular diagnostic testing for infectious diseases including COVID-19, influenza, and other respiratory pathogens through its GeneXpert diagnostic platform. The company maintains two significant Indefinite Delivery Contracts with the Veterans Affairs healthcare system valued at $6.7 million and $32.8 million respectively, establishing Cepheid as a critical supplier of diagnostic testing capabilities across the federal healthcare enterprise. This modest delivery order for diagnostic reagents or test supplies reflects routine ordering under established procurement relationships supporting ongoing clinical laboratory operations.